A Win For TransCode Therapeutics Inc.
Thu, May 01, 2025 at 07:34 PM
TransCode Therapeutics Inc. (RNAZ:NASDAQ) shot up at $0.56, representing a gain of 38.7%. On Thu, May 01, 2025, RNAZ:NASDAQ hit a New 2-Week High of $0.56. The stock got featured on our News Catalysts scanner on Thu, May 01, 2025 at 03:36 PM in the 'BIOTECH' category. From Thu, Apr 17, 2025, the stock recorded 66.67% Up Days and 50.00% Green Days
The stock spiked on Thu, May 01, 2025 at $0.79 with a volume of 129M+.
About TransCode Therapeutics Inc. (RNAZ:NASDAQ)
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.
Top 10 Gainers:
- Classover Holdings Inc. (KIDZ:NASDAQ), 366.09%
- Zoomcar Holdings Inc Com (ZCAR:NASDAQ), 153.07%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 49.44%
- Society Pass Incorporated (SOPA:NASDAQ), 42.86%
- HOOKIPA Pharma Inc. (HOOK:NASDAQ), 38.95%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 38.71%
- BloomZ Inc. (BLMZ:NASDAQ), 37.75%
- Above Food Ingredients Inc. (ABVE:NASDAQ), 36.42%
- TNL Mediagene (TNMG:NASDAQ), 36.2%
- Regencell Bioscience Holdings Limited (RGC:NASDAQ), 28.33%